H Lundbeck B receives Investment Bank Analyst Rating Update
- Investing.com
Pro- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
H Lundbeck B (LUNB)"H Lundbeck B stock price live, this page displays CSE HLUNb stock exchange data. View the HLUNb premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the H Lundbeck B real time stock price chart below.
What Is the H Lundbeck B Stock Price Today?
The H Lundbeck B stock price today is 5.76.
What Is the Stock Symbol for H Lundbeck B?
The stock symbol for H Lundbeck B is ""HLUNb.""
What Stock Exchange Does H Lundbeck B Trade On?
H Lundbeck B is listed and trades on the Copenhagen stock exchange.
Is H Lundbeck B a Good Stock to Buy?
Determining whether H Lundbeck B—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HLUNb quote. (ISIN: DK0061804770)"
What Is the H Lundbeck B Stock Price Today?
The H Lundbeck B stock price today is 5.76.
What Is the Stock Symbol for H Lundbeck B?
The stock symbol for H Lundbeck B is ""HLUNb.""
What Stock Exchange Does H Lundbeck B Trade On?
H Lundbeck B is listed and trades on the Copenhagen stock exchange.
Is H Lundbeck B a Good Stock to Buy?
Determining whether H Lundbeck B—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HLUNb quote. (ISIN: DK0061804770)"
5.76
-0.03(-0.52%)
Closed
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.74
5.82
52 wk Range
4.26
6.62
LUNB Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.745.82
52 wk Range
4.266.62
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.63%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
UnlockEV/EBITDA
UnlockBeta
Book Value / Share
UnlockPrev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.63%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
UnlockEV/EBITDA
UnlockBeta
Book Value / Share
UnlockLUNB Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Neutral
Price Target
50.50
Upside
+17.44%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
- H Lundbeck B receives Investment Bank Analyst Rating Update
- Investing.com
Pro - H Lundbeck B receives Investment Bank Analyst Rating Update
- Investing.com
Pro - H Lundbeck B receives Investment Bank Analyst Rating Update
- Investing.com
Pro - H Lundbeck B receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- H Lundbeck B receives Investment Bank Analyst Rating Update
- Investing.com
Pro - H Lundbeck B receives Investment Bank Analyst Rating Update
- Investing.com
Pro - H Lundbeck B receives Investment Bank Analyst Rating Update
- Investing.com
Pro - H Lundbeck B receives Investment Bank Analyst Rating Update
- Investing.com
Pro - H Lundbeck B receives Investment Bank Analyst Rating Update
- Investing.com
Pro
H Lundbeck B Company Profile
H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally. The company’s principal products include Abilify Maintena/Abilify Maintena for schizophrenia and bipolar I disorder in adults; Brintellix/Trintellix to treat depressive disorders; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat MDD and schizophrenia. It also provides Azilect for treating Parkinson’s disease; Cipralex/Lexapro for depression; Ebixa to treat dementia; Onfi for epilepsy; Sabril for the treatment of refractory complex partial seizures and infantile spasms; Xenazine for chorea; Deanxit for depression; Cipramil for depression and anxiety; and Cisordinol to treat psychosis. The company sells its products primarily to distributors of pharmaceuticals, pharmacies, and hospitals. It has a partnership collaboration with Otsuka Pharmaceuticals Co., Ltd.; and collaboration with Alloy Therapeutics, Inc. for the discovery of novel biologics therapies. The company was founded in 1915 and is headquartered in Valby, Denmark.
Compare LUNB to Peers and Sector
Metrics to compare | LUNB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLUNBPeersSector | |
|---|---|---|---|---|
P/E Ratio | 15.4x | 19.0x | −0.7x | |
PEG Ratio | 1.66 | 0.09 | 0.00 | |
Price/Book | 1.7x | 4.3x | 2.6x | |
Price / LTM Sales | 1.9x | 3.7x | 3.2x | |
Upside (Analyst Target) | - | 14.3% | 47.1% | |
Fair Value Upside | Unlock | 12.9% | 7.3% | Unlock |
Dividends
Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 2.71
Dividend Yield
1.63%
Industry Median 2.22%
Annualised payout
0.0939
Paid annually
5-Years Growth
-
Growth Streak
FAQ
What Is the H Lundbeck B (LUNB) Stock Price Today?
The H Lundbeck B stock price today is 5.76
What Stock Exchange Does H Lundbeck B Trade On?
H Lundbeck B is listed and trades on the Vienna stock exchange.
What Is the Stock Symbol for H Lundbeck B?
The stock symbol for H Lundbeck B is "LUNB."
Does H Lundbeck B Pay Dividends? What’s The Current Dividend Yield?
The H Lundbeck B dividend yield is 1.63%.
What Is the H Lundbeck B Market Cap?
As of today, H Lundbeck B market cap is 5.63B.
What is H Lundbeck B Earnings Per Share?
The H Lundbeck B EPS is 2.71.
From a Technical Analysis Perspective, Is LUNB a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.